T. Rowe Price Associates’s BioNTech BNTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-313,789
| Closed | -$35.8M | – | 3043 |
|
|
2024
Q4 | $35.8M | Sell |
313,789
-5,080
| -2% | -$579K | ﹤0.01% | 852 |
|
|
2024
Q3 | $37.9M | Buy |
318,869
+266,667
| +511% | +$31.7M | ﹤0.01% | 828 |
|
|
2024
Q2 | $4.2M | Sell |
52,202
-393
| -0.7% | -$31.6K | ﹤0.01% | 1276 |
|
|
2024
Q1 | $4.85M | Sell |
52,595
-9,562
| -15% | -$882K | ﹤0.01% | 1224 |
|
|
2023
Q4 | $6.56M | Buy |
62,157
+1,544
| +3% | +$163K | ﹤0.01% | 1162 |
|
|
2023
Q3 | $6.59M | Hold |
60,613
| – | – | ﹤0.01% | 1129 |
|
|
2023
Q2 | $6.54M | Sell |
60,613
-300
| -0.5% | -$32.4K | ﹤0.01% | 1141 |
|
|
2023
Q1 | $7.59M | Sell |
60,913
-723,365
| -92% | -$90.1M | ﹤0.01% | 1104 |
|
|
2022
Q4 | $118M | Sell |
784,278
-472,031
| -38% | -$70.9M | 0.02% | 464 |
|
|
2022
Q3 | $169M | Sell |
1,256,309
-591,626
| -32% | -$79.8M | 0.03% | 393 |
|
|
2022
Q2 | $276M | Buy |
1,847,935
+321,110
| +21% | +$47.9M | 0.03% | 396 |
|
|
2022
Q1 | $260M | Sell |
1,526,825
-10,898
| -0.7% | -$1.86M | 0.03% | 461 |
|
|
2021
Q4 | $396M | Buy |
1,537,723
+373,884
| +32% | +$96.4M | 0.04% | 393 |
|
|
2021
Q3 | $318M | Sell |
1,163,839
-866,822
| -43% | -$237M | 0.03% | 435 |
|
|
2021
Q2 | $455M | Sell |
2,030,661
-44,245
| -2% | -$9.91M | 0.04% | 358 |
|
|
2021
Q1 | $227M | Buy |
2,074,906
+500,085
| +32% | +$54.6M | 0.02% | 519 |
|
|
2020
Q4 | $128M | Buy |
1,574,821
+377,177
| +31% | +$30.7M | 0.01% | 642 |
|
|
2020
Q3 | $82.9M | Buy |
1,197,644
+900,644
| +303% | +$62.4M | 0.01% | 713 |
|
|
2020
Q2 | $19.8M | Buy |
+297,000
| New | +$19.8M | ﹤0.01% | 1149 |
|